SecurityPTH / PowerShares Exchange-Trade Fund Trust (73935X351)
Institutional Owners53
Institutional Shares1,073,644
Institutional Value$ 88,921,000 USD

Institutional Stock Ownership and Shareholders()

PTH / PowerShares Exchange-Trade Fund Trust Institutional Ownership

PowerShares Exchange-Trade Fund Trust (NASDAQ:PTH) has 53 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,073,644 shares. Largest shareholders include Morgan Stanley, UBS Group AG, Royal Bank Of Canada, Bank Of America Corp /de/, HighTower Advisors, LLC, Wells Fargo & Company/mn, Raymond James & Associates, G&s Capital Llc, LPL Financial LLC, and Stephens Inc /ar/.
PowerShares Exchange-Trade Fund Trust (NASDAQ:PTH) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/pth"><img src="https://images.fintel.io/us-pth-so.png" alt="PTH / PowerShares Exchange-Trade Fund Trust Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-08 13F-HR Parallel Advisors, LLC 400 400 0.00 29 30 3.45
2018-07-19 13F-HR David R. Rahn & Associates Inc. 9,478 0 -100.00 722 0 -100.00
2018-05-10 13F-HR JP Morgan Chase & Co 2,815 1,414 -49.77 203 108 -46.80
2018-05-14 13F-HR MORGAN STANLEY 182,876 168,800 -7.70 13,180 12,857 -2.45
2018-05-15 13F-HR JANE STREET GROUP, LLC 37,616 35,187 -6.46 2,331 2,680 14.97
2018-04-30 13F-HR Private Advisory Group LLC 11,678 11,783 0.90 842 897 6.53
2018-04-24 13F-HR SignalPoint Asset Management, LLC 12,036 10,566 -12.21 567 805 41.98
2018-05-15 13F-HR JANE STREET GROUP, LLC Put 53,100 0 -100.00 3,827 0 -100.00
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 5,434 1,945 -64.21 391 148 -62.15
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 63,035 47,931 -23.96 4,543 3,651 -19.63
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 7,108 7,257 2.10 512 553 8.01
2018-04-19 13F-HR Janney Montgomery Scott LLC 0 3,204 0 244
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 1 1 0.00 0 0
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 89,127 88,330 -0.89 6,424 6,729 4.75
2018-05-11 13F-HR First Allied Advisory Services, Inc. 2,571 0 -100.00 184 0 -100.00
2018-04-24 13F-HR NewSquare Capital LLC 86 86 0.00 6 7 16.67
2018-07-19 13F-HR BENJAMIN F. EDWARDS & COMPANY, INC. 3,814 0 -100.00 291 0 -100.00
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 13,492 9,283 -31.20 584 628 7.53
2018-05-25 13F-HR/A SUNTRUST BANKS INC 14,336 0 -100.00 749 0 -100.00
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 834 834 0.00 60 64 6.67
2018-05-15 13F-HR HighTower Advisors, LLC 73,308 73,237 -0.10 5,280 5,582 5.72
2018-07-20 13F-HR Steward Partners Investment Advisory, Llc 10,575 0 -100.00 805 0 -100.00
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 8,544 7,020 -17.84 616 537 -12.82
2018-05-09 13F-HR ENVESTNET ASSET MANAGEMENT INC 15,119 16,367 8.25 1,089 1,254 15.15
2018-04-24 13F-HR G&s Capital Llc 41,727 41,052 -1.62 3,007 3,127 3.99
2018-05-10 13F-HR Stratos Wealth Partners, LTD. 1,163 1,071 -7.91 84 82 -2.38
2018-05-15 13F-HR TWO SIGMA SECURITIES, LLC 3,821 0 -100.00 275 0 -100.00
2018-04-11 13F-HR First Capital Advisors Group, LLC. 2,140 163
2018-05-14 13F-HR Acorn Wealth Advisors, Llc 238 238 0.00 17 19 11.76
2018-05-04 13F-HR Financial Management Professionals, Inc. 30,266 30,555 0.95 2,181 2,327 6.69
2018-05-11 13F-HR STIFEL FINANCIAL CORP 14,412 19,491 35.24 1,042 1,487 42.71
2018-04-16 13F-HR Riggs Asset Managment Co. Inc. 114 114 0.00 8 9 12.50
2018-04-30 13F-HR Highland Private Wealth Management 11,783 897
2018-05-09 13F-HR IFP Advisors, Inc 454 454 0.00 33 35 6.06
2018-04-16 13F-HR Westside Investment Management, Inc. 100 100 0.00 7,286 7,260 -0.36
2018-05-09 13F-HR Cambridge Investment Research Advisors, Inc. 21,453 21,118 -1.56 1,546 1,609 4.08
2018-05-11 13F-HR Compagnie Odier SCA 650 50
2018-04-30 13F-HR Certified Advisory Corp 24 1
2018-04-17 13F-HR Calton & Associates, Inc. 8,458 8,529 0.84 676 650 -3.85
2018-05-15 13F-HR WOLVERINE TRADING, LLC Put 4,400 0 -100.00 317 0 -100.00
2018-04-23 13F-HR Advisory Services Network, LLC 41 41 0.00 3 3 0.00
2018-05-15 13F-HR National Asset Management, Inc. 6,767 7,092 4.80 488 541 10.86
2018-05-07 13F-HR Centaurus Financial, Inc. 16,776 16,889 0.67 1,209 1,286 6.37
2018-04-20 13F-HR Seacrest Wealth Management, Llc 350 27
2018-05-15 13F-HR GLENMEDE TRUST CO NA 1,847 1,847 0.00 133 133 0.00
2018-05-15 13F-HR UBS Group AG 120,595 138,547 14.89 8,691 10,553 21.42
2018-05-03 13F-HR STEPHENS INC /AR/ 0 37,930 0 2,889
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 71 0 -100.00 5 0 -100.00
2018-05-09 13F-HR Transamerica Financial Advisors, Inc. 245 117 -52.24 18 9 -50.00
2018-05-18 13F-HR CIBC World Markets Inc. 6,025 4,475 -25.73 434 341 -21.43
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 4,676 30,092 543.54 337 2,302 583.09
2018-05-11 13F-HR CITIGROUP INC 1,262 1,474 16.80 91 113 24.18
2018-05-15 13F-HR American Financial Network Advisory Services Llc 332 0 -100.00 24 0 -100.00
2018-05-15 13F-HR Advisor Group, Inc. 3,599 4,131 14.78 259 315 21.62
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 14,323 3,970 -72.28 769 304 -60.47
2018-05-11 13F-HR CITADEL ADVISORS LLC 3,970 304
2018-04-26 13F-HR CWM, LLC 91 91 0.00 7 7 0.00
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 156 83 -46.79 11 6 -45.45
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 68,939 79,640 15.52 4,969 6,066 22.08
2018-05-14 13F-HR AMERIPRISE FINANCIAL INC 10,136 6,290 -37.94 731 479 -34.47
2018-05-15 13F-HR LPL Financial LLC 34,879 38,722 11.02 2,514 2,949 17.30
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 55,199 71,484 29.50 3,979 5,445 36.84
2018-07-19 13F-HR EXANE DERIVATIVES 2,395 0 -100.00 180,753 0 -100.00
2017-01-13 13F-HR MetLife Securities, Inc 36,860 1,953 -94.70 531 94 -82.30
2018-05-14 13F-HR Commonwealth Equity Services, Llc. 3,492 3,492 0.00 252 265 5.16
2018-05-04 13F-HR Warren Averett Asset Management, LLC 110 0 -100.00 8 0 -100.00

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

How To Avoid The Worst Sector ETFs Q1 2018

2018-03-28 seekingalpha
The following presents the least and most expensive sector ETFs as well as the worst overall sector ETFs per our Q1'18 sector ratings.

CUSIP: 73935X351